Stay updated on Intratumoral SD-101 + Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral SD-101 + Pembrolizumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Location sections for Alabama, Arizona, California, Colorado, Florida, Georgia, Illinois, Iowa, Michigan, Minnesota, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Texas, Utah, Virginia, West Virginia, New South Wales, South Australia, and Western Australia. The page revision was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-19T12:27:12.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.2 (replacing v3.3.1). No visible changes to study content or page behavior.
    Difference
    0.0%
    Check dated 2025-11-28T00:57:20.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Publications section now includes a note that items are automatically filled from PubMed and may not all pertain to the study. The page revision label was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-21T00:41:44.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page no longer displays the funding-lapse notice that warned updates may be delayed due to appropriations, while the core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T21:38:04.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Non-substantive UI and text adjustments were observed; the core study details (title, conditions, eligibility, primary/secondary outcomes) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T11:53:12.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Added v3.2.0 update; removed a specific resource (Head and neck squamous cell carcinoma) and removed v3.0.2.
    Difference
    0.3%
    Check dated 2025-10-01T05:18:16.000Z thumbnail image

Stay in the know with updates to Intratumoral SD-101 + Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral SD-101 + Pembrolizumab Clinical Trial page.